Abstract:Undoubtedly, the advent of antibiotics in the 19th century had a substantial impact, increasing human life expectancy. However, a multitude of scientific investigations now indicate that we are currently experiencing a phase known as the post-antibiotic era. There is a genuine concern that we might regress to a time before antibiotics and confront widespread outbreaks of severe epidemic diseases, particularly those caused by bacterial infections. These investigations have demonstrated that epidemics thrive under environmental stressors such as climate change, the depletion of natural resources, and detrimental human activities such as wars, conflicts, antibiotic overuse, and pollution. Moreover, bacteria possess a remarkable ability to adapt and mutate. Unfortunately, the current development of antibiotics is insufficient, and the future appears grim unless we abandon our current approach of generating synthetic antibiotics that rapidly lose their effectiveness against multidrug-resistant bacteria. Despite their vital role in modern medicine, medicinal plants have served as the primary source of curative drugs since ancient times. Numerous scientific reports published over the past three decades suggest that medicinal plants could serve as a promising alternative to ineffective antibiotics in combating infectious diseases. Over the past few years, phenolic compounds, alkaloids, saponins, and terpenoids have exhibited noteworthy antibacterial potential, primarily through membrane-disruption mechanisms, protein binding, interference with intermediary metabolism, anti-quorum sensing, and anti-biofilm activity. However, to optimize their utilization as effective antibacterial drugs, further advancements in omics technologies and network pharmacology will be required in order to identify optimal combinations among these compounds or in conjunction with antibiotics.

Alternative natural sources for a new generation of antibacterial agents

Bacterial Natural Product Drug Discovery for New Antibiotics: Strategies for Tackling the Problem of Antibiotic Resistance by Efficient Bioprospecting

The re-emerging role of microbial natural products in antibiotic discovery

New antibiotics from bacterial natural products

Genome mining and prospects for antibiotic discovery

Natural antibiotics against antimicrobial resistance: sources and bioinspired delivery systems

Recent Progress in Terrestrial Biota Derived Antibacterial Agents for Medical Applications

Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era

Alternatives to conventional antimicrobial drugs: a review of future prospects

Back to Nature: Medicinal Plants as Promising Sources for Antibacterial Drugs in the Post-Antibiotic Era

The Science of Antibiotic Discovery

Bacterial Pathogens: Potential Source For Antimicrobial Peptides

Natural Products Resolve Antibiotic Resistance Crisis

Recent progress of antibacterial natural products: Future antibiotics candidates

Sophisticated natural products as antibiotics

Using bacterial genomes and essential genes for the development of new antibiotics

Harnessing Gram‐negative bacteria for novel anti‐Gram‐negative antibiotics

Bioprospecting for Antibacterial Drugs: a Multidisciplinary Perspective on Natural Product Source Material, Bioassay Selection and Avoidable Pitfalls

Antimicrobials from endophytes as novel therapeutics to counter drug-resistant pathogens

The “Three Cs” of Novel Antibiotic Discovery and Production through Synthetic Biology: Biosynthetic Gene Clusters, Heterologous Chassis, and Synthetic Microbial Consortia

Novel targets to develop new antibacterial agents and novel alternatives to antibacterial agents